학술논문

190P Outcomes from the Asian region of the phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for patients (pts) with resected pancreatic cancer (PC)
Document Type
Abstract
Source
In Annals of Oncology November 2020 31 Supplement 6:S1313-S1313
Subject
Language
ISSN
0923-7534